Literature DB >> 23381980

Clinical experience in invasive fungal infections.

Patrícia Pacheco1, Ana Sofia Ventura, Teresa Branco, Lucília Gonçalves, Célia Carvalho.   

Abstract

Lung infections caused by invasive filamentous fungi are very rare conditions in AIDS, but must be considered in patients with profound immune suppression especially in the presence of additional risk factors, such as hematologic malignancies, corticosteroid therapy, neutropenia, and chemotherapy. The authors report a case of dual lung infection caused by Aspergillus and Mucor, which occurred in a 34-year-old AIDS patient who was treated with chemotherapy for oral plasmablastic lymphoma. The case presented clinically with low grade fever and pulmonary cavitation, which suggested tuberculosis. After extensive investigation the diagnosis of mucormycosis was established and the patient was treated sequentially with liposomal amphotericin B and posaconazole. Despite a reduction in the size of the pulmonary cavitation, improvement of the lung interstitial infiltrates and clinical recovery, the patient was submitted to cardiothoracic surgery given the aggressive behavior of this invasive fungus. Histology of the surgical specimen showed numerous hyphae with a morphologic pattern compatible with Aspergillus as well as hyphae that were suggestive of Mucor.

Entities:  

Mesh:

Year:  2013        PMID: 23381980     DOI: 10.1007/s40261-012-0017-1

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  9 in total

Review 1.  In vitro activity of antifungals against Zygomycetes.

Authors:  A Alastruey-Izquierdo; M V Castelli; I Cuesta; O Zaragoza; A Monzón; E Mellado; J L Rodríguez-Tudela
Journal:  Clin Microbiol Infect       Date:  2009-10       Impact factor: 8.067

Review 2.  Molecular tools for identification of Zygomycetes and the diagnosis of zygomycosis.

Authors:  E Dannaoui
Journal:  Clin Microbiol Infect       Date:  2009-10       Impact factor: 8.067

3.  Endobronchial mucormycosis.

Authors:  J F Donohue
Journal:  Chest       Date:  1983-03       Impact factor: 9.410

Review 4.  Pulmonary mucormycosis: results of medical and surgical therapy.

Authors:  M Tedder; J A Spratt; M P Anstadt; S S Hegde; S D Tedder; J E Lowe
Journal:  Ann Thorac Surg       Date:  1994-04       Impact factor: 4.330

5.  Spectrum of zygomycete species identified in clinically significant specimens in the United States.

Authors:  E Alvarez; D A Sutton; J Cano; A W Fothergill; A Stchigel; M G Rinaldi; J Guarro
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

Review 6.  Zygomycosis: conventional laboratory diagnosis.

Authors:  C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2009-10       Impact factor: 8.067

Review 7.  Current experience in treating invasive zygomycosis with posaconazole.

Authors:  O A Cornely; J J Vehreschild; M J G T Rüping
Journal:  Clin Microbiol Infect       Date:  2009-10       Impact factor: 8.067

Review 8.  Zygomycosis.

Authors:  Corina E Gonzalez; Michael G Rinaldi; Alan M Sugar
Journal:  Infect Dis Clin North Am       Date:  2002-12       Impact factor: 5.982

Review 9.  Zygomycosis.

Authors:  M G Rinaldi
Journal:  Infect Dis Clin North Am       Date:  1989-03       Impact factor: 5.982

  9 in total
  5 in total

Review 1.  Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature.

Authors:  Maddalena Chermetz; Margherita Gobbo; Katia Rupel; Giulia Ottaviani; Giancarlo Tirelli; Rossana Bussani; Roberto Luzzati; Roberto Di Lenarda; Matteo Biasotto
Journal:  Mycopathologia       Date:  2016-06-27       Impact factor: 2.574

Review 2.  Pulmonary Mucormycosis Over 130 Years: A Case Report and Literature Review.

Authors:  Hasan S Yamin; Amro Y Alastal; Izzedin Bakri
Journal:  Turk Thorac J       Date:  2017-01-01

3.  A long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case.

Authors:  Setareh Davoudi; Paolo Anderlini; Gregory N Fuller; Dimitrios P Kontoyiannis
Journal:  Mycopathologia       Date:  2014-08-03       Impact factor: 2.574

4.  Antifungal efficacy of itraconazole-loaded TPGS-b-(PCL-ran-PGA) nanoparticles.

Authors:  Lixin Qiu; Bicheng Hu; Hongbo Chen; Shanshan Li; Yuqian Hu; Yi Zheng; Xinxing Wu
Journal:  Int J Nanomedicine       Date:  2015-02-17

5.  Histological Spectrum of Post Covid Debridement Tissues: Salient Histomorphological Features With Respect to Identification Fungal Elements.

Authors:  Preeti Agarwal; Devanshi Brajesh Dubey; Madhu Kumar; Pratima Verma; Menka Mishra; Shalini Rawat; Damini Singh; Virendra Verma; Ravindra Kumar Garg
Journal:  Clin Pathol       Date:  2022-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.